Results of a randomized phase II study of two schedules of bryostatin-I in patients with malignant melanoma: experience with the multivariate stopping rule

Saved in:
Bibliographic Details
Published inEuropean journal of cancer (1990) Vol. 35; p. S374
Main Authors Belanger, K., Tozer, R., Burdette-Radoux, S., Davis, M., Lohmann, R., Zee, B., Wainman, N., Seymour, L.
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 01.09.1999
Online AccessGet full text

Cover

More Information
ISSN:0959-8049
1879-0852
DOI:10.1016/S0959-8049(99)81937-6